translates into phenotypes that are more prone to spontaneous reversion than those used for genetic selec tion in mic roorganisms. Finally, the vec tors c urrently available for genetic manipulation of c ultured c ells are relatively primitive.
We therefore developed the MaRX system, a spec ialized strategy to fac ilitate func tion-based gene isolation in mammalian c ells. T his system relies on two c onc epts to overc ome impediments to the use of genetic methods in c ultured c ells. First is the use of nuc leic ac id as a "virtual mutagen" rather than relianc e on c hemic al or other mutagens. Cloned c omplementary DNAs (c DNAs), either in the sense or antisense orientation, are used to reversibly alter gene expression thereby c reating a phenotype in a c ultured c ell. Sec ond, the tendenc y of suc h phenotypes to revert spontaneously has been ac c ommodated. T he system allows effic ient introduc tion of c DNA libraries into target c ells, and allows effic ient rec overy of either individual genes or c omplex sublibraries from c ell populations that have been enric hed on the basis of a spec ific biologic al c harac teristic . As shown in Fig. 1 , the essenc e of the approac h is the ability to rapidly filter c omplex mixtures of c lones through multiple rounds of phenotypic selec tion, termed c yc le c loning.
Fig. 1. T he MaRX c yc le.
A normalized DNA library is c onverted into a library of retroviruses by using a pac kaging c ell line (linX). T hen, these infec ted rec ipient c ells are selec ted or enric hed on the basis of a spec ific biologic al property. Proviruses are rec overed and used for virus produc tion and subsequent rounds of sc reening.
T he diffic ulty of manipulating large numbers of tissue c ulture c ells c oupled with the need to sc reen c omplex libraries dic tates the need for effic ient gene transfer. T o ac hieve this goal in a wide range of c ell types, we relied on newly designed, replic ation-defic ient retrovirus vec tors. T he genomic struc ture and replic ation of these viruses is well understood, thus simplifying modific ation of existing systems for use as genetic tools. Furthermore, stable integration of rec ombinant retroviruses allows phenotypes to be assessed over many c ell generations. However, downstream analysis of c DNAs that elic it selec ted phenotypes is c omplic ated by the need to rec over a single-c opy provirus from the host genome. Previous applic ations of the retroviral vec tors for func tional c loning have relied on polymerase c hain reac tion (PCR) for isolation of virusborne c DNA fragments (6, 7, 10) . T his approac h may be suffic ient when only a few c ell c lones need to be analyzed. However, PCR-based approac hes are ill suited for manipulation of c omplex populations.
We addressed the problem of effic iently rec overing integrated retroviruses by inc orporating into MaRX the ability to be exc ised from genomic DNA by the ac tion of a site-spec ific rec ombinase either in vitro or in vivo ( effec t of exc ision in vivo is loss of the integrated virus. T his provides a simple mec hanism to demonstrate that the phenotype of a selec ted c ell requires expression of the exogenous genetic element--a reversion test (Fig. 2B) . Exc ision in vitro is ac c omplished by treating purified genomic DNA with the appropriate rec ombinase. T his generates a c irc ular molec ule c arrying the sequenc e responsible for generating the desired phenotype. T o fac ilitate rec overy of this exc ised virus, we have inc luded within the MaRX provirus an optimized mini-plasmid (~700 base pairs in length). T hus, the exc ised provirus c an be resc ued simply by transforming rec ombinase-treated genomic DNA into highly c ompetent Escherichia coli. T his exc ision protoc ol also allows rec overy of individual genes or c omplex mixtures of proviruses. (1) were infec ted with a MaRX virus that direc ts b-galac tosidase expression (2) . T hese c ells were then transduc ed with a retrovirus that direc ts rec ombinase expression (3). Upon rec ombinase expression and c ontinued passage (4), the phenotype of these c ells (b-galac tosidase expression) is reverted.
T he exc ised MaRX provirus has a single intac t long-term repeat sequenc e. Upon transfec tion into an appropriate pac kaging c ell line, the rec overed provirus yields infec tious retrovirus with an effic ienc y similar to that of the intac t MaRX vec tor. T herefore, verific ation of a genetic resc ue c an be ac hieved without manipulation of individual c andidate fragments. T he ability to resc ue a library of func tional proviruses from a selec ted c ell population allows a gene to be enric hed from c omplex mixture through multiple rounds of phenotypic selec tion (through use of a single c ell line; multiple, different c ell lines; or selec tion c riteria). Bec ause many interesting phenotypes are "leaky," the ability to pass c omplex populations through multiple rounds of selec tion (c yc le c loning) allows ac c ess to a wider range of biologic al problems.
T he primary motivation for c reating the MaRX system was to enable the c loning of mammalian genes by relying solely on their func tional properties. T o test the effic ac y of our approac h, we sought to reproduc e one of the first marker resc ue experiments to suc c eed in c ultured c ells, the c loning of the ras onc ogene (8) .
NIH-3T 3 c ells were infec ted with a MaRX c DNA library derived from a tumor c ell line. A sc reen for transformation yielded a number of foc i. Many of the isolates that displayed the most highly transformed phenotype c arried MaRX proviruses enc oding ac tivated ras alleles. In a sc reen that took only 8 weeks, ras was isolated four independent times from 20 standard (100 mm) tissue c ulture plates.
T hus, this simple model verified our ability to isolate relevant genes through phenotypic selec tion.
T he ability to probe the func tion of spec ific genes through the c reation of loss-of-func tion "alleles" is at the heart of any genetic methodology. T he diploid nature of mammalian c ells nec essitates the use of unc onventional approac hes to the c reation of "rec essive" mutants. Effec tive inhibition of gene func tion c an oc c ur following expression of antisense RNAs (11) . We used this method to test the MaRX system's ability to assess the c onsequenc es of loss of the tumor suppressor gene p53.
We c reated a direc tional, randomly primed c DNA library c onsisting of fragments of the p53 c oding sequenc e, bec ause antisense mRNA fragments may inhibit gene expression more effec tively than c omplete antisense mRNAs (10) . T his library was transferred into A3 c ells, a murine embryonic fibroblast (MEF) derivative that ec topic ally expresses a c onditional version of p53 from a strong viral promoter. Shift of these c ells to the permissive temperature resulted in c ell-c yc le arrest. Infec tion of A3 c ells with the antisense p53 mini-library allowed c olony formation at a frequenc y of roughly 10 -3 per c ell.
Proviruses c ontaining interfering p53 fragments were rec overed from c lones that resisted growth arrest. Expression of the most highly represented fragments resulted in a >90% inhibition of p53 protein expression and in effic ient resc ue of growth arrest. In primary c ells (MEF c ells), the selec ted fragments inhibited expression of endogenous p53, extended life-span, and protec ted the c ell from DNA-damaging agents. Exc ision of the p53-inhibitory provirus (the "virtual mutagen") from any of these c ell populations reverted the p53-null phenotype, demonstrating a c ontinuous dependenc e on the antisense RNA. Expression of a full-length p53 antisense RNA produc ed effec ts that were indistinguishable from those seen with the selec ted fragments. T hus, at least in this instanc e, use of a restric ted antisense gene fragment was not required to generate a phenotype.
T hese results demonstrate that the MaRX system c an c reate reversible, loss-offunc tion phenotypes. Antisense RNAs c an work effec tively against endogenous mRNAs and c an even inhibit expression from ec topic ally expressed transc ripts.
We have further validated the MaRX system in a range of biologic al c ontexts.
For example, we investigated the roles of tumor suppressor func tion in c ellular senesc enc e, studying multiple genes and their interac tions, and of inhibitory c ytokines in growth c ontrol (12, 13) . A searc h for genes that protec t from onc ogene-dependent c ell death revealed a potential onc ogene (14) , and a sc reen for bypass of p53 func tion unc overed a possible explanation for the long-mysterious link between c hronic inflammation and c anc er (15) . We even deployed the MaRX system to identify genes that c onfer resistanc e to widely used pharmac eutic als (16) . T he versatility of the approac h is exemplified by adaptation of the MaRX system to c reate two different versions of a high-throughput, homologous, mammalian sec retion trapping system that is c apable of identifying type I, type II, and unc onventional sec retion signals (17).
We have c reated a c oherent system of reagents that enables a powerful genetic sc reening approac h to a broad range of biologic al problems in mammalian c ells. In princ iple, this system c an be used to investigate any aspec t of biology or pathobiology that c an be rec apitulated in a c ell-c ulture model. In due c ourse, we antic ipate elaboration of MaRX into a rec ombinant mutagen for whole-animal studies.
